Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Bergman

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Rheumatology|October 17, 2015
Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?Theodore Pincus, Martin J Bergman, Yusuf Yazici
The Journal of Rheumatology|October 16, 2021
Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity?Theodore Pincus, Martin J Bergman, Yusuf Yazici
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2021
Use of Precision Medicine to Guide Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et alStanley B Cohen, Theodore Mellors, Martin J Bergman
Rheumatic Diseases Clinics of North America|December 8, 2009
How to collect an MDHAQ to provide rheumatology vital signs (function, pain, global status, and RAPID3 scores) in the infrastructure of rheumatology care, including some misconceptions regarding the MDHAQTheodore Pincus, Alyce M Oliver, Martin J Bergman
Rheumatic Diseases Clinics of North America|December 8, 2009
Complex measures and indices for clinical research compared with simple patient questionnaires to assess function, pain, and global estimates as rheumatology "vital signs" for usual clinical careTheodore Pincus, Martin J Bergman, Ross Maclean, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target: not as simple as it appearsTheodore Pincus, Isabel Castrejón, Martin J Bergman, et al.
Plos One|June 10, 2016
Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview SurveyBrian Walitt, Robert S Katz, Martin J Bergman, et al.
Rheumatology (Oxford, England)|December 11, 2019
Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trialsEdward C Keystone, Harris A Ahmad, Yusuf Yazici, et al.
Autoimmune Diseases|December 26, 2013
Composite Indices Using 3 or 4 Components of the Core Data Set Have Similar Predictive Ability to Measure Disease Activity in RA: Evidence from the DANCER and REFLEX StudiesMartin J Bergman, William Reiss, Carol Chung, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by DavisTheodore Pincus, Joel A Block, Yusuf Yazici, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|October 17, 2015
Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?Theodore Pincus, Martin J Bergman, Yusuf Yazici
The Journal of Rheumatology|October 16, 2021
Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity?Theodore Pincus, Martin J Bergman, Yusuf Yazici
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2021
Use of Precision Medicine to Guide Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et alStanley B Cohen, Theodore Mellors, Martin J Bergman
Rheumatic Diseases Clinics of North America|December 8, 2009
How to collect an MDHAQ to provide rheumatology vital signs (function, pain, global status, and RAPID3 scores) in the infrastructure of rheumatology care, including some misconceptions regarding the MDHAQTheodore Pincus, Alyce M Oliver, Martin J Bergman
Rheumatic Diseases Clinics of North America|December 8, 2009
Complex measures and indices for clinical research compared with simple patient questionnaires to assess function, pain, and global estimates as rheumatology "vital signs" for usual clinical careTheodore Pincus, Martin J Bergman, Ross Maclean, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target: not as simple as it appearsTheodore Pincus, Isabel Castrejón, Martin J Bergman, et al.
Plos One|June 10, 2016
Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview SurveyBrian Walitt, Robert S Katz, Martin J Bergman, et al.
Rheumatology (Oxford, England)|December 11, 2019
Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trialsEdward C Keystone, Harris A Ahmad, Yusuf Yazici, et al.
Autoimmune Diseases|December 26, 2013
Composite Indices Using 3 or 4 Components of the Core Data Set Have Similar Predictive Ability to Measure Disease Activity in RA: Evidence from the DANCER and REFLEX StudiesMartin J Bergman, William Reiss, Carol Chung, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by DavisTheodore Pincus, Joel A Block, Yusuf Yazici, et al.
Pageof 4